Last Posted: Feb 16, 2017
Mendelian Randomization as an Approach to Assess Causality Using Observational Data.
Sekula Peggy et al. Journal of the American Society of Nephrology : JASN 2016 Nov 27(11) 3253-3265
When Will Mendelian Randomization Become Relevant for Clinical Practice and Public Health?
GD Smith, JAMA, February 14, 2017
Association of Body Mass Index with DNA Methylation and Gene Expression in Blood Cells and Relations to Cardiometabolic Disease: A Mendelian Randomization Approach
MM Mendelson et al, PLOS MEdicine, January 2017
Genetics: Implications for Prevention and Management of Coronary Artery Disease.
Assimes Themistocles L et al. Journal of the American College of Cardiology 2016 Dec 68(25) 2797-2818
MR-Base: a platform for systematic causal inference across the phenome using billions of genetic associations
G Hemani et al, BioXIRV preprints, December 2016
Mendelian randomization in (epi)genetic epidemiology: an effective tool to be handled with care.
Latvala Antti et al. Genome biology 2016 17(1) 156
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.